Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Organisation › Details

Vect-Horus (FR)

VECT-HORUS is a French biotechnology company that designs and develops peptide vectors to facilitate the delivery of drugs or imaging agents to the brain and other organs. By combining pharmaceutical agents with peptide vectors, VECT-HORUS enables their transport across the BBB that significantly prevents the brain delivery of most drugs. From this perspective, VECT-HORUS has identified and validated highly specific and stable vectors protected by several families of patents and patent applications. The company has already demonstrated proof of concept of the technology in animal models by vectorizing various molecules, among which the endogenous neuropeptide neurotensin, which is currently undergoing regulatory preclinical studies. The technology has also enabled the signing of a scientific collaboration agreement with SANOFI in the field of neurodegenerative diseases. Founded in 2005, VECT-HORUS is a spin-off from the CNRS-AMU NICN laboratory directed by Dr Michel Khrestchatisky. Its founders are Alexandre Tokay, Chairman, and Michel Khrestchatisky, Scientific Counsel. VECT-HORUS has 17 employees, mostly in R&D. VECT-HORUS is identified by the CNRS as one of the 15 success stories among 1 000 spin-offs from its laboratories. *

 

Period Start 2005-12-01 splitoff
  Predecessor CNRS (Centre National de la Recherche Scientifique) (FR)
Product Industry vector (biotech)
Person Person Tokay, Alexandre (Vect-Horus 201506 CEO + Co-founder)
     
Region Region Marseille
  Country France
  Street Boulevard Pierre Dramard
Faculte de Medecine Nord
  City 13344 Marseille Cedex 15
  Tel +33-6-3040-3695
    Address record changed: 2020-12-02
     
Basic data Employees B: 11 to 50 (2015-06-17)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px




» top